NCT00571155

Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery

Prospective Trial of Intravenous Levetiracetam in Patients With Primary Brain Tumors and at Least One Symptomatic Seizure Who Undergo Biopsy or Cytoreductive Surgery (HELLO-study)

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: University Hospital Tuebingen · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the feasibility, efficacy and safety of intravenous and oral antiepileptic treatment with levetiracetam in patients with primary brain tumors and symptomatic epilepsy in the period of neurosurgical intervention.

Conditions

• Primary Brain Tumor
• Epilepsy

Interventions

Type	Name	Description
DRUG	levetiracetam	oral and intravenous dosing 2000-3000 mg per day

Timeline

• Start date: 2007-12-01
• Primary completion: 2009-08-01
• Completion: 2009-08-01
• First posted: 2007-12-11
• Last updated: 2009-08-20

Locations

1 site across 1 country: Germany